Explainable Machine Learning Model for Post-SRS Overall Survival Estimation in Renal Cell Carcinoma Brain Metastases Patients

Clicks: 9
ID: 329885
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #56 of 65 articles by views in Neuro-Oncology Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Brain metastases (BM) from renal cell carcinoma (RCC) significantly affect survival, and disease-specific prognostic tools for patients undergoing stereotactic radiosurgery (SRS) remain limited. We aimed to identify prognostic factors and develop an interpretable machine learning (ML) model for individualized risk stratification following SRS. Methods We retrospectively analyzed 169 patients with RCC BM treated with SRS between November 2015 and May 2021 in this retrospective cohort study. Univariate Cox regression were performed. ML analyses used a comprehensive survival modeling framework integrating multiple algorithms and ensemble strategies, with final model selection based on nested cross-validation (CV) performance and interpretation using Shapley Additive Explanations (SHAP). Performance was evaluated using the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC), Brier score, and calibration metrics; a web-based calculator was developed. Results Median overall survival (OS) was 1.73 years (95% confidence interval (CI), 1.26–2.60). In the test cohort, the selected model elastic net–regularized Cox regression (α = 0.2) achieved a C-index of 0.68 with 95% CI: 0.60-0.76 and a 1-year AUC of 0.74 with 95% CI: 0.61-0.86. Using the training cohort median risk score, patients were stratified into low- and high-risk groups with significantly different OS in both cohorts. SHAP analysis identified pre-intervention Karnofsky Performance Status , BM locations, age at intervention, pre-intervention tumor volume, and number of BM as influential predictors. Conclusions We developed an interpretable ML survival model that enables individualized OS prediction and clinically meaningful risk stratification after SRS while reflecting established prognostic factors.
Reference Key
openalex_W7214423067 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Semiha Özgül, Melis Parabas, Peng Li, Zuhair Majeed, Yusuf Açıkgöz, Sherise Desiree Ferguson, Eric Jonasch, Subha Perni, Thomas Hendrix Beckham, Jing Li, Dima Suki, Hasanov Merve, Elshad Hasanov
Are you one of these authors? Claim your profile
Journal Neuro-Oncology Practice
Year 2026
DOI
10.1093/nop/npag097
URL
https://doi.org/10.1093/nop/npag097
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.